Ads
related to: anti-cancer treatment- BENDEKA® Therapy
Learn About An Infusion Therapy
Therapy Plan For Your Patients.
- Dosing & Administration
Get More Information On BENDEKA®
Approved Indications.
- About BENDEKA®
Get Information About BENDEKA®
For Your Patients & Practice.
- BENDEKA® Treatment
Find Important Information
On BENDEKA® Treatment Options.
- Codes & Reimbursement
Find BENDEKA® Billing Codes.
Learn About Patient Reimbursement.
- Downloadable Resources
Download Patient Resources. Find
Case Studies & HCP Support.
- BENDEKA® Therapy
Search results
Breast cancer surgeon runs a farm where the only crop is wellness
Medical Xpress· 1 day agoMonique Gary, a breast cancer surgeon, is a self-described "Philly girl" who was born in Jefferson...
SOTIO Biotech doses first subject in Phase I solid tumour treatment trial
Clinical Trials Arena via Yahoo Finance· 1 day agoSOTIO Biotech chief medical officer Richard Sachse said: “While anti-PD-1 therapeutics have been a...
Bone Cancer Breakthrough: UCL’s New T-Cell Therapy Shows Promise
SciTechDaily· 19 hours agoA new immunotherapy developed at UCL using engineered immune cells has shown promising preclinical...
New immunotherapy could treat cancer in the bone
Medical Xpress· 19 hours agoOsteosarcoma is the most common bone cancer in teenagers but is still relatively rare, with around 160 new cases each year in the UK. Meanwhile, more...
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena via Yahoo Finance· 6 days agoVerastem’s has Phase II (NCT04625270) and Phase III (NCT06072781) trials ongoing for ovarian cancer ...
FLI1 promotes IFN-γ-induced kynurenine production to impair anti-tumor immunity - Nature...
Nature· 6 hours agoThe immunosuppressive tumour microenvironment in Nasopharyngeal carcinoma (NPC) is a cause of low efficacy of immunotherapies in these tumours. In this study, the authors delineate a FLI1-mediated ...
Plant-Based Diets Lower The Risk Of Prostate Cancer Progressing By 47%
Forbes· 1 day agoA recent JAMA Network Open study of men who were diagnosed with prostate cancer found that people...
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 1 day agoMerck has reported that its Phase III KEYNOTE-522 clinical trial of KEYTRUDA to treat high-risk,...
Isabella Strahan Spent 19th Birthday Unconscious Amid Cancer Battle
E! News via Yahoo News· 2 days agoMichael Strahan's daughter Isabella Strahan threw herself a belated 19th birthday celebration,...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 hour agoPhase 3 CARES-310 study found combination of camrelizumab and rivoceranib continued to show sustained long-term survival compared with sorafenib as a first-line treatment ...
Ad
related to: anti-cancer treatment